Precigen is a biopharmaceutical company based in Davis, CA, dedicated to advancing the field of gene and cell therapies. With a focus on immuno-oncology, autoimmune disorders, and infectious diseases, Precigen utilizes precision technology to develop innovative and affordable biotherapeutics. Their pipeline consists of well-differentiated therapies that undergo rigorous preclinical and clinical testing, aiming for clinical proof-of-concept and eventual commercialization.
Using a combination of non-viral and viral expression systems, genome engineering, and precision bioengineering switch technologies, Precigen designs next-generation therapies that target specific genes and cells, resulting in improved safety and efficacy. With a sense of urgency driven by the devastating impact of diseases like cancer, Precigen strives to make a difference in the lives of patients by advancing medicine with precision.
Generated from the website